Banque Cantonale Vaudoise Exact Sciences Corp Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Exact Sciences Corp stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 5,682 shares of EXAS stock, worth $326,601. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,682

Previous 12,099 53.04%

Holding current value

$326,601

Previous $512,000 24.41%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$42.43 - $70.83 $272,273 - $454,516	-6,417 Reduced 53.04%	5,682 $387,000
Q2 2024 Jul 31, 2024	BUY	$41.33 - $74.26 $217,313 - $390,459	5,258 Added 76.86%	12,099 $512,000
Q1 2024 Apr 10, 2024	BUY	$56.27 - $73.77 $101,004 - $132,417	1,795 Added 35.57%	6,841 $472,000
Q4 2023 Feb 07, 2024	SELL	$59.06 - $75.72 $313,903 - $402,451	-5,315 Reduced 51.3%	5,046 $373,000
Q3 2023 Nov 08, 2023	BUY	$65.94 - $99.04 $77,611 - $116,570	1,177 Added 12.82%	10,361 $706,000
Q2 2023 Aug 09, 2023	BUY	$62.68 - $95.05 $341,292 - $517,547	5,445 Added 145.63%	9,184 $862,000
Q1 2023 Apr 20, 2023	SELL	$47.19 - $70.77 $990 - $1,486	-21 Reduced 0.56%	3,739 $254,000
Q4 2022 Feb 10, 2023	SELL	$30.35 - $53.15 $25,554 - $44,752	-842 Reduced 18.3%	3,760 $185,000
Q3 2022 Oct 17, 2022	SELL	$31.97 - $49.37 $767 - $1,184	-24 Reduced 0.52%	4,602 $149,000
Q2 2022 Aug 02, 2022	BUY	$35.61 - $76.23 $12,071 - $25,841	339 Added 7.91%	4,626 $181,000
Q1 2022 May 09, 2022	SELL	$57.56 - $82.54 $11,512 - $16,508	-200 Reduced 4.46%	4,287 $300,000
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $15,370 - $21,344	212 Added 4.96%	4,487 $350,000
Q3 2021 Oct 29, 2021	BUY	$90.24 - $124.05 $50,083 - $68,847	555 Added 14.92%	4,275 $408,000
Q2 2021 Aug 11, 2021	SELL	$93.66 - $139.27 $16,296 - $24,232	-174 Reduced 4.47%	3,720 $463,000
Q1 2021 May 11, 2021	SELL	$116.57 - $155.01 $154,921 - $206,008	-1,329 Reduced 25.45%	3,894 $513,000
Q4 2020 Feb 05, 2021	SELL	$99.61 - $142.12 $66,937 - $95,504	-672 Reduced 11.4%	5,223 $691,000
Q3 2020 Oct 30, 2020	BUY	$72.92 - $102.01 $74,888 - $104,764	1,027 Added 21.1%	5,895 $600,000
Q2 2020 Jul 22, 2020	BUY	$55.75 - $92.75 $11,596 - $19,292	208 Added 4.46%	4,868 $423,000
Q1 2020 May 14, 2020	SELL	$37.9 - $104.44 $7,163 - $19,739	-189 Reduced 3.9%	4,660 $270,000
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $376,573 - $483,639	4,849 New	4,849 $448,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Exact Sciences Corp Transaction History